Key result
Intralesional triamcinolone and cryosurgery fail to halt lesion progression in angiolymphoid hyperplasia with eosinophilia.
Why the study?
Angiolymphoid hyperplasia with eosinophilia (ALHE) lesions can progress despite initial treatments, necessitating exploration of new therapeutic options.
Does intralesional interferon alfa-2a improve lesions in a patient with angiolymphoid hyperplasia with eosinophilia refractory to triamcinolone and cryosurgery?
Case Report (n=1)
Does intralesional interferon alfa-2a improve lesions in a patient with angiolymphoid hyperplasia with eosinophilia refractory to triamcinolone and cryosurgery?
This case report describes the clinical course of a patient with angiolymphoid hyperplasia with eosinophilia requiring alternative therapy after failing intralesional triamcinolone and cryosurgery.
Hypothesis-generating for combined intralesional triamcinolone and cryosurgery in ALHE; prospective trials needed before clinical adoption.
A 52-year-old white woman presented with a 1-year history of pruritic, erythematous nodules on her right ear and preauricular area (Figure 1). The lesions had a tendency to bleed after minor trauma and had been gradually increasing in size and number. A biopsy was performed, and the findings were consistent with the diagnosis of angiolymphoid hyperplasia with eosinophilia (ALHE). The patient was initially treated with a combination of intralesional triamcinolone acetonide and cryosurgery, at 1- to 4-month intervals. The triamcinolone acetonide therapy was started with 1 to 2 mL intralesionally at 5 mg/mL, and the concentration was gradually increased to 20 mg/mL. The patient’s response was variable, with improvement seen at some visits and worsening noted at others. After 11⁄2 years, and continued progression of lesions, new therapeutic options needed to be considered.
No takes yet. Share an insight, caveat, or question.
Shenefelt et al. (2000) conducted a case report in Angiolymphoid hyperplasia with eosinophilia (ALHE) (n=1). Intralesional triamcinolone acetonide and cryosurgery was evaluated on Clinical response and progression of lesions. A 52-year-old woman with angiolymphoid hyperplasia with eosinophilia experienced continued progression of lesions after 1.5 years of treatment with intralesional triamcinolone acetonide and cryosurgery.
Synapse has enriched one closely related paper. Consider it for comparative context: